In The News
The Wooten Laboratory is a co-sponsor of the Annual Symposia of East Carolina Chapter of Society for Neuroscience (ECCSN) from 2008 to 2012. The annual meetings are held in November each year in Greenville, North Carolina. The Wooten Laboratory has supported the Wooten Lectures given by distinguished clinicians or scientists investigating Alzheimer’s disease and/or other neurodegenerative diseases. The Wooten Laboratory has also funded and presented awards for Best Student Presentation at the symposia.
In January of 2013, Dr. Qun Lu published a paper in The Proceedings of the National Academy of Sciences of the United States of America (PNAS), titled "Small molecule targeting Cdc42-intersectin interaction disrupts Golgi organization and suppresses cell motility".
In January of 2013, the Wooten Laboratory accepted the invitation to present to Eli Lily representatives for partnership discussion on neurodegenerative diseases research.
In November of 2012, the Wooten Laboratory sponsored Dr. Oscar Lopez, Director of University of Pittsburgh Alzheimer's Disease Research Center, as the Wooten Lecturer at the 14th annual Neuroscience Symposium.
In November of 2012, the Wooten Laboratory sponsored Dr. Weiming Xia from VA Hospital in Boston to deliver a talk at the 14th annual Neuroscience Symposium and The Wooten Roundtable Discussion.
In September of 2012, the Wooten Laboratory received a $100,000 donation to accelerate translational research and promote Wooten Laboratory research efforts.
In May of 2012, Dr. Qun Lu received a grant from National Cancer Institute to study RhoGTPase as neuroprotection target in chemotherapy-induced neurodegeneration.
In November of 2011, the Wooten Laboratory sponsored ECU Wooten Laboratory member Dr. Mark Mannie as the Wooten Lecturer in the 13th annual Neuroscience Symposium.
In September of 2011, Dr. Qun Lu, with the assistance and support of ECU Department of Marketing professor Dr. Margy Conchar, produced the Wooten Visibility brochure. It was distributed on Sept. 17, 2011 at the Raleigh Alzheimer's Walk, Oct. 15, 2011 at the Washington Walk, and Nov. 12, 2011 at the Greenville Walk.
In July and September of 2011, Dr. Mark Mannie received two grants from National Institute of Neurological Disorders and Stroke to study therapeutic vaccines (TTV) in murine experimental autoimmune encephalomyelitis (EAE).
In May of 2011, Dr. Qun Lu received funding from PharmaTrophix for Alzheimer's disease drug applications.
In February of 2011, the Wooten Laboratory received a $100,000 donation to accelerate translational research and promote Wooten Laboratory research efforts.
In February of 2011, the Wooten Laboratory established a triple transgenic Alzheimer's disease mouse core under the direction of Dr. Qun Lu. At the same time, the funding of five Wooten projects was announced to investigate the molecular and cellular mechanisms of Alzheimer's disease-like pathogenesis in the triple transgenic mice with Alzheimer type mutations.
In November of 2010, the Wooten Laboratory co-sponsored the 12th annual East Carolina Neuroscience Symposium and the Wooten Lecture by Dr. Sandra Kelly of University of South Carolina.
In October of 2010, Dr. Qun Lu published a paper in Journal of Alzheimer's Disease, titled "Alzheimer's disease-linked presenilin mutation (PS1M146L) induces filamin expression and gamma-secretase independent redistribution".
In September of 2010, Dr. Alex Murashov received a grant from National Institute for Environmental Health Sciences to study microRNA pathway in mechanisms of nanoparticles neurotoxicity.
In February of 2010, the funding of six Wooten projects was announced to investigate the molecular and cellular mechanisms of Alzheimer's disease and other neurological disorders.
In November of 2009, The Wooten Laboratory sponsored Dr. Donald Price, MD, Director of Johns Hopkins University Alzheimer's Disease Center and Dr. Dwight German of University Texas Southwestern Medical Center to deliver the Wooten Lectures on Alzheimer's disease research at 11th Annual Neuroscience Symposium.